BC19-Fiocruz will enable the design and conduct of research, technological development and clinical trials, with the capacity to store up to one and a half million samples of human and non-human biological materials
Fiocruz International News - January 2022
A third AstraZeneca vaccine dose significantly increases neutralizing antibodies levels against the variant. The research was conducted independently by researchers from different institutions, including Fiocruz
The CAS-Fiocruz Webinar on Infectious Diseases brought together researchers from both sides to exchange information on topics such as COVID-19, vaccines, zika, dengue, and other diseases present in Brazil and China
Project to strengthen antimicrobial resistance surveillance system receives CDC funding
The program is a partnership between Fiocruz, the Ministry of Health, Lacen/PR and Unifesp. It aims to reinforce the detection of multidrug-resistant bacteria and fungi in hospitals, train professionals, and enable more accurate and rapid responses
COVID-19: all vaccines administered in Brazil are effective, says report
Vigivac project analysed the four vaccines administered in Brazil, from January to October 2021, showing that all of them confer great protection. Considering serious outcomes in individuals aged 20-80 years, protection ranged from 83% to 99% for all immunizers
"We are in an alert system", says virologist that is part of WHO advisory group
Technical Advisory Group on Sars-CoV-2 Evolution includes Marilda Siqueira, from IOC/Fiocruz: “We know the mutations in the Omicron genome that are markers for potentially higher transmissibility, but we don’t yet know how much of an impact this will have on hospitalizations and deaths”
Socioeconomic impact of COVID-19 will be longer-lasting in vulnerable populations
Research published by The Lancet explains how the economic downturn will be worse in developing countries. Inequalities in health, physical and socioeconomic well-being will widen worldwide, the study predicts
On the agenda of the conversation between Nísia Trindade Lima and Jacqueline Ward, scientific cooperation, the XVI National Malaria Research Meeting and a symposium organized by the Foundation and the NIH
Pietro Lazzeri wants to expand technical and scientific cooperation. He also visited Bio-Manguinhos, where he found out that some machines used in the production of the COVID-19 vaccine came from his country
The exposition at the Brazil Pavilion shows the Foundation's work and even a virtual tour of Campus Manguinhos. The exhibition proposes to discuss health technology, access to health as a universal right, and health in the 2030 Agenda
"What is Open Science?" and "Open Access" were translated from Portuguese into English and Spanish. They integrate the series developed by the Fiocruz Virtual Campus in partnership with several actors of the Foundation